News About: Pharm. Industry
Hyundai, Takeda team up for TachoSil patch
Hyundai Pharm announced Wednesday that it has signed an agreement with Takeda Pharmaceuticals Korea for the exclusive distribution right in Korea of TachoSil (absorbable fibrin sealant patch) for use as an adjunct to ...
29 Korean companies sign deal to transfer formulation technologies to 26 foreign countries
A total of 91 formulation technologies have been transferred by 29 Korean pharmaceutical firms to 26 foreign drug manufacturers since Hanmi Pharm exported the formulation technology of ceftriaxone to Swiss based Roche...
Dong-A Pharm to split into two operating entities
Dong-A Pharm Co., a Korea’s largest drugmaker, said Tuesday that it will split into two operating entities to simplify its corporate structure and boost investor interest.
A board of directors finalized the plan on...
Celltrion awaits market authorization of Remsima from 52 countries
Celltrion, a local biopharmaceutical company, said Monday that it has awaited approval of Remsima from 52 countries as well as the European Medicines Agency (EMA).
Remsima is a biosimilar version of U.S. Merck’s Re...
Daewoong Pharm signs $5 million Easyef export deal
Local drug maker Daewoong Pharmaceutical said Monday it has signed a five million dollar agreement with the Egyptian company EGY-TEC to export its newly developed Easyef ointment for treatment of diabetic foot ulcer.
...
Drug makers eye popular OTC drugs
Some drug firms are rushing to copy popular over-the-counter drugs to soften the blow from government-mandated cuts in drug prices.
Their focus is centered around Yuyu Pharmaceutical’s anti-informatory agent ‘Venop...
Yungin forges strategic tie-up with Novacell
Yungjin Pharmaceutical said Monday that it has forged a strategic alliance with Novacell Technology in an effort to develop new proteomix based biomarkers.
The deal with Novacell is expected to help enhance coopera...
Multinational firms to speed up M&A moves
Multinational drug companies will speed up their M&A moves as part of their efforts to beef up competitiveness.
The U.S. generics company Alvogen Group recently purchased 50.5 percent in shares of mid-sized Kunwha ...
Ilyang, Daewoong sign deal to sell Supect
Ilyang Pharmaceutical Co. said Friday it established a strategic partnership with Daewoong Pharmaceutical Co. to sell Supect, a newly-developed drug for myelogenous leukemia by Ilyang, in Korea.
Under the deal, Ily...
Schenker Korea to build healthcare center
Schenker Korea plans to construct its healthcare center in Korea to incorporate its six logistics warehouses for better services.
The Korean unit of Germany based company is now providing a variety of distribution ...
